The global neuroscience antibodies and assays market size was valued at USD 3,723.43 million in 2024 and is expected to reach USD 5,867.03 million, growing at a CAGR of 5.41% from 2025 to 2033. The market is driven by the rising prevalence of neurological and neurodegenerative disorders ... Read More »
October 2025The U.S. blood testing market size was valued at USD 35.90 billion in 2024 and is projected to reach USD 71.41 billion by 2033, growing at a CAGR of 8.1% from 2025 to 2033. The market is primarily driven by the rising prevalence of chronic diseases such as diabetes, cardiovascular condit... Read More »
September 2025The global enzyme immunoassay market size was valued at USD 17.78 billion in 2024 and is projected to reach USD 24.77 billion by 2033, growing at a CAGR of 3.68% from 2025 to 2033. The industry growth can be attributed to the increasing demand for automation in diagnostic tests, increasi... Read More »
September 2025The global neonatal toxicology market size was estimated at USD 280.92 million in 2024 and is projected to reach USD 701.32 million by 2033, growing at a CAGR of 10.73% from 2025 to 2033. This growth is attributed to the increasing incidence of maternal drug use, along with development o... Read More »
September 2025The global non-specific endonucleases market size was valued at USD 362.34 million in 2025 and is expected to reach USD 585.19 million by 2033, growing at a CAGR of 6.27% from 2026 to 2033. This growth is primarily fueled by rising R&D investments in molecular biology and biotechnolo... Read More »
September 2025The Middle East biomarker-based immunoassays market size was estimated at USD 114.23 million in 2024 and is projected to reach USD 159.25 million by 2033, growing at a CAGR of 3.61% from 2025 to 2033. The market growth is driven by the rising global burden of chronic diseases such as can... Read More »
September 2025The global advanced cancer diagnostics market size was estimated at USD 58.30 billion in 2024 and is expected to reach USD 127.07 billion by 2033, expanding at a CAGR of 9.05% from 2025 to 2033. The market is driven by several strong factors. Rising global cancer incidence continues to expand demand for early and pr... Read More »
September 2025The global high and ultra-high-field nuclear magnetic resonance spectroscopy market size was estimated at USD 528.37 million in 2023 and is projected to grow at a CAGR of 5.70% from 2024 to 2035. Market growth can be attributed to the increasing funding & investment initiatives for n... Read More »
September 2025The global body fluid collection and diagnostics market size was estimated at USD 34.35 billion in 2024 and is anticipated to reach USD 61.99 billion by 2033, growing at a CAGR of 6.87% from 2025 to 2033. Rapid results, cost-effectiveness, and early prognosis of diseases are some of the ... Read More »
September 2025The global diagnostic enzymes market size was valued at USD 5.15 billion in 2024 and is projected to reach USD 9.75 billion by 2033, growing at a CAGR of 7.47% from 2025 to 2033. This growth highlights the growing need for quicker and more reliable healthcare solutions as the world faces... Read More »
September 2025The global ovarian cancer diagnostics market size was estimated at USD 1.74 billion in 2024 and is projected to reach USD 3.11 billion by 2033, growing at a CAGR of 6.73% from 2025 to 2033. The ovarian cancer diagnostics market is advancing rapidly, driven by biomarker discovery, federal... Read More »
September 2025The global syphilis testing market size was estimated at USD 515.21 million in 2024 and is projected to reach USD 1,375.60 million by 2033, growing at a CAGR of 11.89% from 2025 to 2033. Key market growth drivers for dual HIV/syphilis rapid diagnostics include the rising global burden of... Read More »
September 2025The Japan autoimmune disease diagnostics market size was estimated at USD 365.49 million in 2024 and is expected to reach USD 640.45 million by 2033, growing at a CAGR of 6.6% from 2025 to 2033. As the world’s fastest-aging nation, with over 29% of its population aged 65 or older, ... Read More »
September 2025The U.S. filter integrity test market size was estimated at USD 32.12 million in 2024 and is projected to reach USD 47.36 million by 2033, growing at a CAGR of 4.44% from 2025 to 2023. The market is primarily driven by the rapid growth of the biopharmaceutical industry. Increasing demand for biologics, monoclonal an... Read More »
September 2025The China lung cancer screening market size was estimated at USD 554.17 million in 2024, and is projected to reach USD 1,492.56 million by 2033, growing at a CAGR of 11.83% from 2025 to 2033. Several key factors drive market growth, including the high prevalence of lung cancer, adva... Read More »
September 2025The Middle East breast cancer diagnostics market size was estimated at USD 95.25 million in 2024 and is projected to reach USD 165.10 million by 2033, growing at a CAGR of 6.39% from 2025 to 2033. The market is primarily driven by the rising incidence of breast cancer, which remains the ... Read More »
September 2025The Middle East oncology based molecular diagnostics market size was estimated at USD 82.5 million in 2024 and is projected to grow at a CAGR of 5.6% from 2025 to 2033. Growth in the Middle East oncology-based molecular diagnostics market is driven by rising cancer incidence, increasing ... Read More »
September 2025The Middle East thyroid cancer diagnostics market size was estimated at USD 89.64 million in 2024 and is projected to reach USD 142.27 million by 2033, growing at a CAGR of 5.4% from 2025 to 2033. The market shows rising demand, driven by gender-skewed incidence, with female rates notabl... Read More »
September 2025The U.S. breast cancer diagnostics market size was estimated at USD 2.26 billion in 2024 and is projected to reach USD 4.53 billion by 2033, registering a CAGR of 8.21% from 2025 to 2033. The growth can be attributed to the increasing prevalence of breast cancer and rising government ini... Read More »
September 2025The U.S. thyroid cancer diagnostics market size was estimated at USD 1.02 billion in 2024 and is projected to reach USD 1.48 billion by 2033, growing at a CAGR of around 4.30% from 2025 to 2033. Thyroid cancer diagnostics in the U.S. are rapidly evolving, with 2025 estimates projecting 4... Read More »
September 2025